Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries

By Evans, Gail E. | American Journal of Law & Medicine, April 1, 2008 | Go to article overview

Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries


Evans, Gail E., American Journal of Law & Medicine


In May 2006, at the World Health Assembly, the governments of Kenya and Brazil called on fellow nations to promote the development of the public health tools necessary to build the research capacity of developing countries. That call was again made at the G8 Summit in June 2007,1 when the national science academies of the G8 nations and Brazil, China, India, Mexico and South Africa signed a statement on the promotion and protection of innovation. Highlighting the need to balance the protection of intellectual property with the need to foster access to knowledge and remove barriers to innovation, the statement calls on world leaders to:

Work with developing countries to build systems of science, technology and innovation for economic and social development, and to promote the education and training of their future leaders particularly in science, engineering, technology, and medicine.2

As to the means of working with developing countries to build innovative capacity, the Network of African Science Academies (NASAC), made the following recommendations to the leaders of the G8 countries:

That the G8 governments provide financial, scientific and technical support for the efforts of the African scientific community, including NASAC and the Association of African Universities (AAU), to work with the academies of science, engineering and medicine in G8 countries, to promote International cooperation in science and technology for the purposes of advancing the Millennium Development Goals (MDGs) in Africa.3

The prominence of public health within the internationally agreed framework of eight goals and eighteen targets provides an indication of the magnitude of the problem. Public health issues feature in no less than four of the eight millennium development goals. Goals Four, Five and Six speak respectively of reducing child mortality, improving maternal health, and combating epidemic diseases such as HIV/ AIDS and malaria. Over and above the goals specifically directed to public health, Goal Eight is especially relevant for the development of an indigenous supply of affordable medicines. The eighth MDG aspires to create a "Global Partnership for Development" that is, in turn, offset by Target Seventeen, entitled "Access to Medicines." This Target exhorts fellow Members of the United Nations, in cooperation with pharmaceutical companies, to provide access to affordable, essential drugs in developing countries.4

According to the World Health Organization (WHO), the principal causes of death in the developing world are respiratory infections, HIV/AIDS, infections at birth, diarrhoeal disease5 and tropical diseases such as malaria.6 Nevertheless, it is commonly claimed that only 10% of the world's medical research is devoted to conditions that account for 90% of the global disease burden.7 Irrespective of whether such estimates represent an accurate indication of the imbalance between R&D and the risks to public health, a sustainable supply of affordable medicines will require action to mobilize collaborations between public research organizations (PROs) for drug discovery and partnerships for drug development within the pharmaceutical industry.8 Thus, there remains a need to develop better drugs and vaccines for diseases that are largely confined to developing countries.

Many drugs for diseases prevalent in the developing world are antiquated or have serious side effects and many organisms that cause these diseases are developing resistance to treatment.9 Although effective medicines are available for many of the most prevalent diseases, ensuring access in resourcepoor countries is of major concern due to problems of cost, delivery, and healthcare support. The factors that are expected to catalyze the need for indigenous R&D in developing countries are epidemics, an aged population and the growing incidence of lifestyle-related diseases giving rise to increased healthcare expenditure. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Author Advanced search

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.